
Christopher W. Fulton
Examiner (ID: 16699, Phone: (571)272-2242 , Office: P/2855 )
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2859, 3641, 2406, 2899, 2841, 2855, 3108, 2856 |
| Total Applications | 3373 |
| Issued Applications | 2875 |
| Pending Applications | 85 |
| Abandoned Applications | 419 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5626103
[patent_doc_number] => 20060264608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Bi-directional synthesis of oligoguanidine transport agents'
[patent_app_type] => utility
[patent_app_number] => 11/375795
[patent_app_country] => US
[patent_app_date] => 2006-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10774
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20060264608.pdf
[firstpage_image] =>[orig_patent_app_number] => 11375795
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/375795 | Bi-directional synthesis of oligoguanidine transport agents | Mar 13, 2006 | Abandoned |
Array
(
[id] => 5264486
[patent_doc_number] => 20090117171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'Compositions and methods for treatment of macular degeneration and related conditions'
[patent_app_type] => utility
[patent_app_number] => 11/375587
[patent_app_country] => US
[patent_app_date] => 2006-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 25817
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20090117171.pdf
[firstpage_image] =>[orig_patent_app_number] => 11375587
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/375587 | Compositions and methods for treatment of macular degeneration and related conditions | Mar 12, 2006 | Abandoned |
Array
(
[id] => 243332
[patent_doc_number] => 07589066
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-15
[patent_title] => 'Potent and specific immunoproteasome inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/374652
[patent_app_country] => US
[patent_app_date] => 2006-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16189
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 243
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/589/07589066.pdf
[firstpage_image] =>[orig_patent_app_number] => 11374652
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/374652 | Potent and specific immunoproteasome inhibitors | Mar 12, 2006 | Issued |
Array
(
[id] => 8797270
[patent_doc_number] => 08436139
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-07
[patent_title] => 'Peptide-based immunization therapy for treatment of atherosclerosis'
[patent_app_type] => utility
[patent_app_number] => 11/373682
[patent_app_country] => US
[patent_app_date] => 2006-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4707
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11373682
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/373682 | Peptide-based immunization therapy for treatment of atherosclerosis | Mar 9, 2006 | Issued |
Array
(
[id] => 5683498
[patent_doc_number] => 20060199768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-07
[patent_title] => 'Inhibitors of RecA activities for control of antibiotic-resistant bacterial pathogens'
[patent_app_type] => utility
[patent_app_number] => 11/371373
[patent_app_country] => US
[patent_app_date] => 2006-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 33667
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20060199768.pdf
[firstpage_image] =>[orig_patent_app_number] => 11371373
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/371373 | Inhibitors of RecA activities for control of antibiotic-resistant bacterial pathogens | Mar 6, 2006 | Abandoned |
Array
(
[id] => 292480
[patent_doc_number] => 07544772
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-09
[patent_title] => 'Methods for regulating inflammatory mediators and peptides useful therein'
[patent_app_type] => utility
[patent_app_number] => 11/367449
[patent_app_country] => US
[patent_app_date] => 2006-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 24
[patent_no_of_words] => 22857
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/544/07544772.pdf
[firstpage_image] =>[orig_patent_app_number] => 11367449
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/367449 | Methods for regulating inflammatory mediators and peptides useful therein | Mar 5, 2006 | Issued |
Array
(
[id] => 221068
[patent_doc_number] => 07608614
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-27
[patent_title] => 'Process for preparing macrocyclic compounds'
[patent_app_type] => utility
[patent_app_number] => 11/276573
[patent_app_country] => US
[patent_app_date] => 2006-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9225
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/608/07608614.pdf
[firstpage_image] =>[orig_patent_app_number] => 11276573
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/276573 | Process for preparing macrocyclic compounds | Mar 5, 2006 | Issued |
Array
(
[id] => 5130783
[patent_doc_number] => 20070207180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'Synthetic polypeptide-containing bioapplicable material and film-forming material'
[patent_app_type] => utility
[patent_app_number] => 11/365832
[patent_app_country] => US
[patent_app_date] => 2006-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 30502
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20070207180.pdf
[firstpage_image] =>[orig_patent_app_number] => 11365832
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/365832 | Synthetic polypeptide-containing bioapplicable material and film-forming material | Mar 1, 2006 | Abandoned |
Array
(
[id] => 4753152
[patent_doc_number] => 20080161227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'Blood Pressure Lowering Peptides From Glycomacropeptide'
[patent_app_type] => utility
[patent_app_number] => 11/884448
[patent_app_country] => US
[patent_app_date] => 2006-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19489
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20080161227.pdf
[firstpage_image] =>[orig_patent_app_number] => 11884448
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/884448 | Blood pressure lowering peptides from glycomacropeptide | Feb 22, 2006 | Issued |
Array
(
[id] => 4887560
[patent_doc_number] => 20080261892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Acid Addition Salts of Ac-Phscn-Nh2'
[patent_app_type] => utility
[patent_app_number] => 11/883584
[patent_app_country] => US
[patent_app_date] => 2006-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15685
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20080261892.pdf
[firstpage_image] =>[orig_patent_app_number] => 11883584
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/883584 | Acid Addition Salts of Ac-Phscn-Nh2 | Jan 31, 2006 | Abandoned |
Array
(
[id] => 8165294
[patent_doc_number] => 08173840
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-08
[patent_title] => 'Compounds with high therapeutic index'
[patent_app_type] => utility
[patent_app_number] => 11/343557
[patent_app_country] => US
[patent_app_date] => 2006-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 78865
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 351
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/173/08173840.pdf
[firstpage_image] =>[orig_patent_app_number] => 11343557
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/343557 | Compounds with high therapeutic index | Jan 29, 2006 | Issued |
Array
(
[id] => 5051864
[patent_doc_number] => 20070032409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Bradykinin receptor antagonists and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/341395
[patent_app_country] => US
[patent_app_date] => 2006-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19210
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20070032409.pdf
[firstpage_image] =>[orig_patent_app_number] => 11341395
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/341395 | Bradykinin receptor antagonists and uses thereof | Jan 25, 2006 | Abandoned |
Array
(
[id] => 314956
[patent_doc_number] => 07524926
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-28
[patent_title] => 'Mucin hypersecretion inhibitors and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/335564
[patent_app_country] => US
[patent_app_date] => 2006-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26557
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/524/07524926.pdf
[firstpage_image] =>[orig_patent_app_number] => 11335564
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/335564 | Mucin hypersecretion inhibitors and methods of use | Jan 19, 2006 | Issued |
Array
(
[id] => 5113529
[patent_doc_number] => 20070197445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-23
[patent_title] => 'Compounds for control of appetite'
[patent_app_type] => utility
[patent_app_number] => 11/333889
[patent_app_country] => US
[patent_app_date] => 2006-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14632
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20070197445.pdf
[firstpage_image] =>[orig_patent_app_number] => 11333889
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/333889 | Compounds for control of appetite | Jan 17, 2006 | Abandoned |
Array
(
[id] => 5415777
[patent_doc_number] => 20090041664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => '5-Pyrrolidinylsulfonyl Isatin Derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/794878
[patent_app_country] => US
[patent_app_date] => 2005-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16539
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20090041664.pdf
[firstpage_image] =>[orig_patent_app_number] => 11794878
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/794878 | 5-pyrrolidinylsulfonyl isatin derivatives | Dec 21, 2005 | Issued |
Array
(
[id] => 4904482
[patent_doc_number] => 20080113896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Blood Pressure Lowering Peptides in a Single Enzymatic Step'
[patent_app_type] => utility
[patent_app_number] => 11/793390
[patent_app_country] => US
[patent_app_date] => 2005-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 20572
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20080113896.pdf
[firstpage_image] =>[orig_patent_app_number] => 11793390
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/793390 | Blood pressure lowering peptides in a single enzymatic step | Dec 20, 2005 | Issued |
Array
(
[id] => 5655861
[patent_doc_number] => 20060141597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Valency platform molecules comprising aminooxy groups'
[patent_app_type] => utility
[patent_app_number] => 11/303591
[patent_app_country] => US
[patent_app_date] => 2005-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 25581
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0141/20060141597.pdf
[firstpage_image] =>[orig_patent_app_number] => 11303591
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/303591 | Valency platform molecules comprising aminooxy groups | Dec 15, 2005 | Abandoned |
Array
(
[id] => 92203
[patent_doc_number] => 07737112
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-15
[patent_title] => 'Composition for enzyme inhibition'
[patent_app_type] => utility
[patent_app_number] => 11/299265
[patent_app_country] => US
[patent_app_date] => 2005-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 25983
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/737/07737112.pdf
[firstpage_image] =>[orig_patent_app_number] => 11299265
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/299265 | Composition for enzyme inhibition | Dec 6, 2005 | Issued |
Array
(
[id] => 5672949
[patent_doc_number] => 20060178304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Stabilized pharmaceutical peptide compositions'
[patent_app_type] => utility
[patent_app_number] => 11/290634
[patent_app_country] => US
[patent_app_date] => 2005-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6602
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20060178304.pdf
[firstpage_image] =>[orig_patent_app_number] => 11290634
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/290634 | Stabilized pharmaceutical peptide compositions | Nov 29, 2005 | Issued |
Array
(
[id] => 4644435
[patent_doc_number] => 08022040
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-20
[patent_title] => 'Hydroxyapatite-binding peptides for bone growth and inhibition'
[patent_app_type] => utility
[patent_app_number] => 11/720427
[patent_app_country] => US
[patent_app_date] => 2005-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 26
[patent_no_of_words] => 13462
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/022/08022040.pdf
[firstpage_image] =>[orig_patent_app_number] => 11720427
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/720427 | Hydroxyapatite-binding peptides for bone growth and inhibition | Nov 28, 2005 | Issued |